Sarah Krüg is the CEO of Cancer101, a patient advocacy organization. She is also president-elect of the Society for Participatory Medicine, a patient/provider member-driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. As well, Sarah serves as research chair and board member of the Cancer Patient Education Network and on the CPEN Health Literacy Committee. She previously held the position of global education director in the Medical Education Group at Pfizer, where she established the Global Investigator Initiated Research Program. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan-Kettering Cancer Center.